Hyderabad: KIMS Hospitals has achieved a significant milestone by introducing Tulsa-Pro, a groundbreaking treatment for prostate issues, from the Philippines to Turkey. This innovative method addresses localized prostate cancer and enlargement without surgery.
The procedure is performed as a day-care service, requiring no incisions or stitches. Patients can leave the hospital the same day. So far, 13 patients, including individuals from Bahrain, Dubai, and Mauritius, have undergone this treatment successfully. This is the first use of Tulsa-Pro technology in India and throughout Southeast Asia.
Tulsa-Pro stands for Transurethral Ultrasound Ablation of the Prostate. Guided by MRI, it uses ultrasound to remove prostate tissue through the urethra. The result is a less invasive option compared to traditional surgery or radiation, and it helps preserve sexual health.
Dr. Bollineni Bhaskar Rao, Chairman and Managing Director of KIMS Hospitals, stated that Tulsa-Pro allows them to offer comprehensive prostate care, ranging from traditional methods to the latest incision-free treatments.
Dr. Sambit Sahu, Medical Director, noted that the treatment benefits high-risk patients with conditions like stroke or heart surgery, as it eliminates the need for blood transfusions and minimizes drug interaction risks.
Consultant Urologist and Uro-Oncologist Dr. Likhiteshwar Pallagani praised the precision of the robotic, MRI-guided procedure, while Dr. YM Prashanth pointed out its advantages for elderly patients with diabetes or hypertension.
By launching Tulsa-Pro, KIMS Hospitals has set a new standard for prostate care in Asia, strengthening India‘s status as a leader in advanced medical treatments.
